Novartis | NVS - Resultado Líquido

Preço das Ações
147.85
Mudança Diária
4.86 3.40%
Mensal
-3.20%
Anual
32.92%
Q2 Previsão
142.62




Resultado Líquido Alterar Data
AbbVie USD 695M 1.12B 2026-03
Amgen USD 1.33B 1.88B 2025-12
AstraZeneca USD 3.08B 754M 2026-03
Bausch Health Companies USD -1.42B 1.31B 2026-03
Biogen USD 319.5M 368.4M 2026-03
Bristol-Myers Squibb USD 2.68B 1.59B 2026-03
Canopy Growth CAD -62.63M 60.99M 2025-12
Corcept Therapeutics USD 24.29M 4.62M 2025-12
Drreddys Laboratories INR 12.1B 2.08B 2025-12
Eli Lilly USD 6.64B 1.05B 2025-12
Gilead Sciences USD 2.18B 869M 2025-12
GlaxoSmithKline GBP 1.74B 1.1B 2026-03
Glaxosmithkline GBP 846.06M 1.87B 2025-12
J&J USD 5.24B 119M 2026-03
Merck USD 2.96B 2.82B 2025-12
Novartis USD 3.16B 747M 2026-03
Novartis USD 2.41B 1.52B 2025-12
Pacira USD 1.64M 3.8M 2025-12
Perrigo USD -1.42B 1.43B 2025-12
Pfizer USD -1.65B 5.19B 2025-12
Phibro Animal Health USD 27.46M 932K 2025-12
Prestige Brands USD 46.7M 22.44M 2025-12
Roche Holding CHF 5.47B 1.76B 2025-12
Sanofi EUR 1.61B 2.42B 2026-03
Sanofi EUR -801M 3.6B 2025-12
Supernus Pharmaceuticals USD -45.12M 67.62M 2025-09
Zoetis USD 603M 118M 2025-12